SCM
PMVP icon

Sio Capital Management’s PMV Pharmaceuticals PMVP Stock Holding History

Sio Capital Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.81M Buy
3,076,580
+440,032
+17% +$560K 0.55% 44
2025
Q4 		$3.3M Hold
2,636,548
– – 0.52% 40
2025
Q3 		$3.69M Sell
2,636,548
-1,098,848
-29% -$1.52M 0.93% 28
2025
Q2 		$3.96M Hold
3,735,396
– – 1.51% 20
2025
Q1 		$4.07M Buy
3,735,396
+163,229
+5% +$222K 1.21% 21
2024
Q4 		$5.39M Buy
3,572,167
+357,928
+11% +$567K 1.52% 23
2024
Q3 		$4.79M Buy
3,214,239
+505,831
+19% +$782K 1.9% 18
2024
Q2 		$4.39M Buy
+2,708,408
New +$4.88M 1.19% 21
2020
Q4 		– Sell
-1,000
Closed -$36K – 105
2020
Q3 		$36K Buy
+1,000
New +$36.8K 0.01% 89

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sio Capital Management's PMVP Position: Q1 2026 in Review

Sio Capital Management increased its PMV Pharmaceuticals (PMVP) stake by 17% in Q1 2026, buying an estimated $560K and bringing the position to 3,076,580 shares worth $3.81M. The position accounts for 0.55% of the portfolio, ranked #44.

Sio Capital Management first reported a position in PMVP in Q3 2020 and has held it in 9 quarters since. The position peaked at $5.39M in Q4 2024. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • Sio Capital Management held 3,076,580 shares of PMV Pharmaceuticals worth $3.81M as of Q1 2026.
  • Sio Capital Management bought 440,032 PMV Pharmaceuticals shares in Q1 2026, an estimated $560K.
  • PMV Pharmaceuticals made up 0.55% of Sio Capital Management's portfolio in Q1 2026, its #44 holding.
  • Sio Capital Management first reported a position in PMV Pharmaceuticals in Q3 2020 and has held it in 9 quarters since.
  • Sio Capital Management's PMV Pharmaceuticals position peaked at $5.39M in Q4 2024.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on Sio Capital Management's 13F filing for Q1 2026, filed 14 May 2026.